Humana enters $1.0B accelerated stock repurchase agreements with Goldman Sachs and Mizuho

HUMANA INC

Entered ASR agreements to repurchase $1.0B of common stock under existing $3.0B program.
Initial delivery of 1,518,996 shares; final settlement expected in Q4 2022.
Agreements with Goldman Sachs & Co. LLC and Mizuho Markets Americas LLC.
Repurchased shares will be held in treasury or retired.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HUMANA INC entered into ASR Agreement with Goldman Sachs & Co. LLC and Mizuho Markets Americas LLC valued at $1.0 billion (effective 2022-11-02).

Action: entry
Agreement: equity purchase
Counterparty: Goldman Sachs & Co. LLC and Mizuho Markets Americas LLC
Value: $1.0 billion
Effective: 2022-11-02

Exact text from the filing

On November 2, 2022, Humana Inc. (“Humana”) entered into separate accelerated stock repurchase agreements (each, an “ASR Agreement”) with each of Goldman Sachs & Co. LLC (“Goldman Sachs”) and Mizuho Markets Americas LLC (“Mizuho” and, together with Goldman Sachs, the “Dealers”) to repurchase an aggregate of $1.0 billion of Humana’s common stock

View on SEC.gov

Browse all material agreements →

HUMANA INC filing history →

Source: SEC EDGAR

accession 0001193125-22-276332

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.